1 Exosomes Market Size And Share | Industry Report, 2030 2 Grand View Research, Ovarian Cancer Diagnostics Market 2024-2030 3 Breast Cancer Therapeutics Market Growth, Trends & Dynamics, 2027 (fortunebusinessinsights.com) 2 INOVIQ Limited CEO’s Report INOVIQ is advancing nextgeneration diagnostics and therapeutics for significant unmet needs in global oncology markets. INOVIQ is advancing next-generation diagnostics and therapeutics for significant unmet needs in global oncology markets. Our FY25 achievements have strengthened our exosome leadership position with proprietary technologies, commercial products and a robust pipeline of research tools, diagnostics and therapeutics. EXOSOME PLATFORM DRIVING GROWTH AND VALUE The strategic pillars driving growth and value across our business are underpinned by our proprietary technology platforms that are embedded in our on-market research tools and higher-value diagnostics and therapeutics pipeline. Research tools are our commercially available ‘technology-in-a-box’ solutions for exosome isolation that are generating revenue and accelerating adoption of exosome diagnostics. These exosome technologies underpin our clinical-stage ovarian cancer diagnostic and our preclinical CAR-exosome therapy for solid tumours. Our product strategy leverages the exosome platform to deliver integrated solutions for earlier cancer detection and treatment to transform patient outcomes. INOVIQ aims to deliver increasing return on investment as we scale from research tools to diagnostics and therapeutics, aligning our priorities with higher-value global market opportunities. EXOSOME PLATFORM Proprietary exosome technology platform underpinning products & pipeline Embedded value in INOVIQ products and services US$794.2m global exosome research market by 20301 US$5.5b global ovarian cancer diagnostics market by 20302 US$55.3b global breast cancer therapeutics market in 20273 › Establishes INOVIQ as a leading exosome company › Delivers solutions for precise exosome isolation, engineering and loading › Enables transformative applications across research, diagnostics and therapeutics RESEARCH TOOLS Exosome isolation tools for biomarker discovery and diagnostics › Global distribution partner in place for market development and commercial success › Delivers early revenue from sales of research tools and services › Potential licensing income from future commercial diagnostics using EXONET DIAGNOSTICS Exosome tests for screening, liquid biopsies & companion diagnostics › Faster-to-market diagnostics to deliver mid-term partners and revenue › Commercialisation pathway established with existing exosome diagnostics on-market as LDTs and BDD from US FDA THERAPEUTICS Exosome therapeutics to target and destroy solid tumours › High-value therapeutics to deliver blue-sky ROI › Leverages existing exosome technology, capabilities & expertise › Potential first-in-class CAR-exosome therapy with cost, logistics, safety & efficacy advantages 1 2 3 4
RkJQdWJsaXNoZXIy MjE2NDg3